Ventana and MedImmune collaborate to develop immunohistochemistry assay

10-Jun-2014 - Ventana Medical Systems, Inc. and MedImmune announced they are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma. This includes the recently commenced MEDI4736 ATLANTIC ...

Frost & Sullivan determines a real and urgent need for novel cancer diagnostics tests

Nucleic acid based tests address the need for tests that aid in the early detection and prevention of cancer

06-Feb-2013 - The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on detection and diagnosis of cancer using mainly blood, faeces, urine tests or genetic tests. Testing methods are now gradually ...

Olink Bioscience and Olink Genomics in a project aimed to improve cancer treatment

15-Sep-2009 - Olink Bioscience and its sister company Olink Genomics is participating in the project "Companion Diagnostics Initiative" which is financed by Vinnova and aims to develop improved cancer diagnostics to increase survival rate of patients with colorectal cancer. The project is coordinated by ...

Olink Bioscience and AH diagnostics sign distributorship agreement for the Danish and Norwegian markets

19-Aug-2009 - Olink Bioscience has signed a distributorship agreement with AH diagnostics for distribution of the Duolink® in situ PLA™ product line in Denmark and Norway. “AH diagnostics has a strong presence on the molecular biology and immunology markets in Denmark and Norway and with its focus on ...

NextGen Sciences and Expression Pathology to provide protein biomarker discovery and measurement in tissue

01-Jul-2008 - NextGen Sciences, Inc (Ann Arbor, MI), a provider of biomarker services, and Expression Pathology, Inc. (Gaithersburg, MD), a leader in tissue protein analysis, announced that they have signed a commercial agreement to provide protein biomarker services in formalin-fixed paraffin-embedded (FFPE) ...

LifeSpan BioSciences to release 20,000 immunohistochemistry-validated reagent antibodies

Leader in antibody evaluation and validation expands focus to include development and sales of antibodies validated for use in immunohistochemistry

13-Jun-2008 - LifeSpan BioSciences, Inc., announced an initiative to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years. The leader in immunohistochemistry (IHC) antibody validation research since 1995, LifeSpan expanded its product focus to include the development and ...

Transplantation Safety: New Virus Detected Using Genome Sequencer Technology

11-Feb-2008 - 454 Life Sciences, a part of Roche Applied Science, announced that researchers at Columbia University and Victorian Infectious Disease Reference Laboratory have discovered a new virus that was responsible for the deaths of three transplant recipients. The research explains how the previously ...

New Study Reveals Signaling Pathways Required for Expansion of Pancreas Stem Cells

17-May-2006 - A team of scientists at The Scripps Research Institute has published a new study (Journal of Biological Chemistry) of important signaling pathways that are required for the expansion of pancreas stem cells, work that may lead to strategies to prevent or reverse insulin-dependent diabetes mellitus ...

GANYMED lead antibodies show excellent efficacy and safety in mouse tumor models

10-Apr-2006 - GANYMED Pharmaceuticals AG announced that several monoclonal lead antibodies directed against the company's GC182 cancer target have shown excellent efficacy against solid human tumors in mouse xenograft models. No toxicity was observed. The results fully confirm earlier experiments, where ...

Cancer Research Yields Promising Results

Closing Gap between Research Advances and Clinical Practice Crucial to Development of European

04-Aug-2005 - Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either ...